3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
58
Prostatic Neoplasms, Castration-Resistant
4
Metastatic Castration-resistant Prostate Cancer
4
Prostate Cancer Metastatic
2
Neoplasm Metastasis
2
Metastatic Castration-Resistant Prostate Cancer
2
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Stage II Prostate Adenocarcinoma
1
Sleep Initiation and Maintenance Disorders
1
Prostatic Diseases
1
Prostate Adenocarcinoma
1
Ovarian Neoplasms
1
Oligometastatic Prostate Carcinoma
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms by Site
1
Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone Refractory Prostate Cancer
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration Resistant Prostate Cancer
1
Male Urogenital Diseases
1
Genital Neoplasms, Male
1
Fatigue
1
Depression
1
Dementia
1
Cognitive Dysfunction
1
Carcinoma, Transitional Cell
1
Interventions
pembrolizumab
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
cabozantinib
3
Nivolumab
3
cemiplimab
2
Ipilimumab
2
sodium thiosulfate
1
relacorilant
1
lenvatinib
1
fludarabine phosphate
1
dostarlimab
1
Radiation
1
Mitotane
1
Interleukin-13
1
Fluorodeoxyglucose F18
1
Floxuridine
1
E-7386
1
Drug Therapy
1
Dexamethasone
1
Cytoreduction Surgical Procedures
1
Cyclophosphamide
1
Cisplatin
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adrenocortical Carcinoma
×
Abiraterone Acetate
×
1 year
×
Clear all
No trials found.